Category: Clinical Breakthroughs
-
Assessing Risk Factors in Critically Ill COVID-19 Patients
Certain factors are associated with increased risk of death in critically ill COVID-19 patients, according to recent Northwestern Medicine studies.
-
Drug Proves Ineffective in Slowing Diabetic Kidney Disease
A drug commonly used to reduce serum urate levels proved ineffective in slowing disease progression in patients with diabetic kidney disease, according to a recent study.
-
Heart Failure, Hypertensive Deaths Rise in Black Women and Men
Deaths due to heart failure and hypertensive heart disease are increasing in the U.S. — particularly in Black women and men — despite medical and surgical advances in heart disease management, according to a new Northwestern Medicine study.
-
Shortened Resident Shifts Didn’t Decrease Errors
Residents working shifts of 16 hours or less didn’t make fewer errors than residents assigned to 24-hour shifts, according to a recent study published in NEJM.
-
Continuous Glucose Monitoring May Help Reduce Hypoglycemia
In older adults with type 1 diabetes, continuous blood glucose monitoring was more effective in reducing hypoglycemia than standard blood glucose monitoring, according to recent findings published in JAMA.
-
Drug Shortens Flu Recovery in Vulnerable Patients
Patients with influenza at risk of complications recovered more quickly after early treatment with the drug baloxavir marboxil, according to a study published in The Lancet Infectious Diseases.
-
COVID-19 Complicates Cancer Treatment
Cancer patients with other comorbidities have a higher risk of dying from complications due to COVID-19, and should discuss the risks and benefits of continuing cancer treatment with their physician, according to a recent study.
-
Novel Drug Improves Survival in Advanced Prostate Cancer
A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
-
Support Tool Aims to Streamline Decision Process for Cesarean Delivery
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
-
Chemotherapy Drug Mitigates Allergic Response
A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
